Showing results (481-490 of 1,787) with videos related to
Sort By:
Pageof 179
Hepatology Communications|October 7, 2025
3D-bioprinted liver cancer models derived from primary hepatocytes for simulating cancer initiation and drug screeningYuanyuan Zhao, Yuxin Li, Wenjie Zhang, et al.Hepatology Communications|October 7, 2025
The prevalence of autoimmune hepatitis is rising: Estimates and trends from a large, multi-ethnic cohort in the United StatesJimmy Yao, Sheng-Fang Jiang, Chandni Kapoor, et al.Hepatology Communications|October 7, 2025
Performance of the multi-target hepatocellular carcinoma blood test: Design and rationale of the ALTUS studyBinu V John, Mark Camardo, Kyle Porter, et al.Hepatology Communications|October 7, 2025
Single-cell atlas of human pediatric liver reveals age-related hepatic gene signaturesRachel D Edgar, Diana Nakib, Damra Camat, et al.Hepatology Communications|October 14, 2025
The pathophysiological role of portal hypertension in metabolic dysfunction-associated steatotic liver diseaseSøren Møller, Sannia M S Sjöstedt, Lise Hobolth, et al.Hepatology Communications|September 29, 2025
TNAP-induced CD47 membrane expression enhances TGF-β1 conversion in liver fibrosisLei Gao, Fengling Peng, Peng Qi, et al.Hepatology Communications|September 22, 2025
Identification of anti-DOK2 antibodies in patients with autoimmune hepatitis via a human protein microarrayKazumichi Abe, Jun Wada, Manabu Hayashi, et al.Hepatology Communications|September 22, 2025
Age-associated B cells enhance tertiary lymphoid structures in the liver and promote HCC formationAnne E Morsing, Kenneth Green, Signe Clausen, et al.Hepatology Communications|October 7, 2020
LPCN 1144 Resolves NAFLD in Hypogonadal MalesSomaya Albhaisi, Kilyoung Kim, Jonathan Baker, et al.Hepatology Communications|June 12, 2022
Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2-/- mouse model of sclerosing cholangitis via immunomodulatory effectsClaudia D Fuchs, Emmanuel D Dixon, Tim Hendrikx, et al.Pageof 179